Plain-English translation of NCT06030752 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing (WMT)—a procedure where cleaned, healthy gut bacteria from donors are given to children with autism. Researchers believe that improving gut bacteria may help reduce autism symptoms. The treatment uses specially cleaned bacteria to reduce side effects compared to traditional approaches.
Very little research has explored whether changing gut bacteria can help autism. This study aims to find out if this treatment is safe and whether it actually improves how children with autism function and feel.
You likely qualify if…
You likely don't qualify if…
You would receive multiple washed microbiota transplantations—a procedure where cleaned bacteria are introduced into your digestive system. Doctors will collect and test stool samples from a healthy donor and from you before treatment, and again three months after treatment to see how your gut bacteria have changed. The study tracks whether the treatment helps with autism symptoms over this time period.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China
Phase
Safety & dosing
Sponsor
The Second Hospital of Nanjing Medical University
Collaborators
Nanjing Medical University
Enrollment target
~80 participants
Started
September 2023
Primary completion
April 2027
Age range
3 Years – 17 Years
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Faming Zhang, PhD
The Second Hospital of Nanjing Medical University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.